Revenue segments as reported by the company.

Total Oral, Personal and Home Care

Pet Nutrition

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative expenses

Other (income) expense, net

Goodwill and indefinite-lived intangible impairment charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Colgate-Palmolive

Ajax is a brand of cleaning products of Colgate-Palmolive.

Ajax

Speed Stick is a brand of deodorant/antiperspirant that, as the name suggests, comes in stick form. The product is owned by its parent company, Colgate-Palmolive. It was formerly known as "Mennen Speed Stick" prior to Colgate-Palmolive's purchase of The Mennen Company. Currently, the products feature the words "by Mennen" in a small font on the label. Speed Stick comes in both deodorant and antiperspirant forms. Speed Stick is both a sponsor and the official antiperspirant of the NHL.

Speed Stick

Irish Spring is the brand name of a deodorant soap, first marketed by the Colgate-Palmolive company in 1970. Irish Spring currently has nine variants.

Irish Spring

Mennen is a brand owned in most parts of the world by the Colgate-Palmolive Company. Its most notable product, Mennen Speed Stick, with its fougère perfume and green wide stick, was the market leader among deodorants and antiperspirants for men for many years.

Mennen

Softsoap is the trade name of Colgate-Palmolive's liquid hand soap and body wash.

Softsoap

Tom's of Maine is a brand name and manufacturing company of personal care products with only natural ingredients and a majority-owned subsidiary of Colgate-Palmolive since 2006. The company's products are intentionally made without ingredients that are chemically derived, environmentally damaging, or are tested on animals. While most of its products are vegan, some contain propolis and/or beeswax sourced from bees.

Tom's of Maine

Colgate-Palmolive Co. engages in the manufacturing and distribution of consumer products. It operates through the Oral, Personal, and Home Care and Pet Nutrition segments. The Oral, Personal, and Home Care segment includes toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other similar items. The Pet Nutrition segment offers specialty pet nutrition products manufactured and marketed by Hill’s Pet Nutrition. The company was founded by William Colgate in 1806 and is headquartered in New York, NY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Colgate-Palmolive reports robust Q4 growth and eyes future opportunities

Colgate-Palmolive's Q4 2022 earnings call highlighted strong organic sales growth and positive outlook for 2023.
The company faces challenges such as macroeconomic volatility, raw material costs, and cash flow concerns.
Opportunities lie in investments for future growth, margin improvement, and sustaining shareholder value.
Overall, Colgate-Palmolive remains focused on innovation, market share strength, and long-term success.

Colgate-Palmolive reports strong Q1 performance amidst inflation challenges

Colgate-Palmolive's Q1 performance was strong, with a focus on driving growth and improving margins. Despite challenges like inflation and competitive pressures, the company is leveraging strengths in innovation and brand equity to capitalize on opportunities in emerging markets and non-measured channels.

Colgate-Palmolive reports robust Q2 results and eyes emerging markets

Colgate-Palmolive's Q2 earnings call highlighted strong performance, balanced growth, and strategic focus on restoring gross margins.
The company remains confident in its strategies for consistent profitable growth and increasing shareholder value.
Opportunities in emerging markets and digital transformation are key drivers of future growth and competitiveness.

Colgate-Palmolive posts strong Q3 results, eyes sustained profitability and growth

Colgate-Palmolive's Q3 earnings call reflects a robust performance with a focus on sustainable profit growth and margin expansion. The company's strategic initiatives to address challenges and capitalize on opportunities position it well for future growth and market leadership.

Colgate-Palmolive reports robust performance in 2023, eyes balanced growth

Colgate-Palmolive's Q4 2023 earnings call highlighted strong performance, strategic focus on balanced growth, and opportunities for innovation-driven market expansion. The company faces challenges in managing market volatility and inflationary pressures but is well-positioned for growth. Leveraging strengths in market share, innovation, and strategic investments, Colgate-Palmolive aims for consistent earnings growth in 2024.

Colgate-Palmolive reports resilient Q1 performance and eyes global expansion

Colgate-Palmolive's Q1 2024 performance reflects resilience and strategic growth initiatives despite operational challenges.
Strong balance sheet, focus on innovation, and market expansion strategies position the company for sustainable growth.
Opportunities in Latin America, Europe, and emerging markets offer avenues for continued growth and market share expansion.
Emphasis on digital execution and value creation through innovation drive competitive advantage and market differentiation.

Colgate-Palmolive reports solid Q2 results, focuses on growth strategies

Colgate-Palmolive's Q2 call highlighted a strong performance, strategic focus on growth drivers, and challenges in pricing and consumer behavior. The company aims to leverage its strengths in innovation and brand presence to seize long-term opportunities.

Colgate-Palmolive reports robust Q3 results, eyes sustained growth strategies

Colgate-Palmolive's Q3 performance reflects a resilient business model with a strong focus on innovation and strategic investments.
Despite challenges in North America, the company's overall growth trajectory remains positive, driven by volume expansion and market adaptability.
Management's emphasis on sustained growth through strategic investments underscores a forward-looking approach to navigating market dynamics.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Colgate-Palmolive (CL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Can Colgate-Palmolive (CL) Keep the Earnings Surprise Streak Alive?

Colgate-Palmolive Company (NYSE: CL) acquired Laboratories Filorga in a move which will support growth amid global challenges, according to Bank of America.

Analyst Breaks Down Colgate's Largest Acquisition Since 1995

Colgate (CL) to expand the personal care portfolio with the acquisition of skin care business of France-based Filorga.

Colgate (CL) to Expand Skin Care Range With Filorga Buyout

Consumer goods giant Colgate-Palmolive is soon to be one asset larger.

Colgate-Palmolive's $1.7 billion buy

Colgate-Palmolive Co  said on Thursday it would buy Laboratoires Filorga Cosmétiques' skin care business for 1.50 billion euros ($1.69 billion).

Colgate to buy skin care business of France's Filorga for $1.69 billion

Colgate's (CL) strong surprise trend, higher pricing, strong innovation and expansion efforts bode well. However, high input costs and currency headwinds concerns.

Colgate's (CL) Growth Efforts Well on Track Amid Soft Margins

American Water Works

Alphabet

Johnson & Johnson

Southern Company

AT&T

Waste Management

Walmart

Add these proven companies to you list of stocks to buy for the long, long haul. They were all built to last.

10 Best Stocks to Buy and Hold Forever!

Brookfield Infrastructure Partners L.P.

Charter Communications

Equinix

Worldpay

According to GuruFocus' list of 52-week highs, these guru stocks have reached their 52-week highs.

5 Companies Reach Yearly Highs (June 18)

General Mills

Medifast

Newell Brands

Newell's (NWL) dismal sales surprise trend can be attributed to lower core sales and adverse foreign currency. Nevertheless, its Transformation Plan appears encouraging.

Newell Loses 22% YTD: Can Its Transformation Plan Aid Stock?

Plaintiff Patricia Schmitz will be awarded $4.8 million in damages from each company.

J&J, Colgate ordered to pay nearly $10 million in California talc cancer case

Colgate (CL) exhibits strong surprise trend, owing to accelerated investments in brands, higher pricing and strong innovation along with expansion in new markets and channels.

Here's Why Colgate (CL) Deserves a Place in Your Portfolio

Colgate-Palmolive (CL) reported earnings 30 days ago. What's next for the stock?

Colgate-Palmolive (CL) Up 3.7% Since Last Earnings Report: Can It Continue?

The relaunches of Colgate Total and Hill's Science Diet drive sales, but margins are still under pressure.

Colgate-Palmolive Tops Analyst Estimates, but Headwinds Remain

Does Colgate-Palmolive (CL) have what it takes to be a top stock pick for momentum investors? Let's find out.

Here's Why Colgate-Palmolive (CL) is a Great Momentum Stock to Buy

Colgate's (CL) investments in brands, higher pricing and strong innovation along with expansion in new markets and channels bode well.

Colgate (CL) Hits 52-Week High: What's Behind the Rally?

Colgate-Palmolive Company's (CL) CEO Noel Wallace on Q1 2019 Results - Earnings Call Transcript

Colgate (CL) delivers top and bottom-line beat in first-quarter 2019, benefiting from favorable pricing and volume growth. However, adverse currency remains a hurdle.

Colgate (CL) Q1 Earnings & Sales Top Estimates, Stock Up

Colgate-Palmolive Co. said Friday it had net income of $560 million, or 65 cents a share, in the first quarter, down from $634 million, or 72 cents a share, in the year-earlier period.

Colgate-Palmolive tops estimates in latest quarter

Clorox

Hershey

Bottom Line: Colgate, Clorox, and Hershey are great dividend Blue Chip buys at the right price.

3 Dividend Blue Chips That Retirees Will Love

Unilever

UN vs. CL: Which Stock Is the Better Value Option?

UN or CL: Which Is the Better Value Stock Right Now?

Colgate's (CL) growth efforts make us confident that it will likely retain the robust bottom-line surprise trend. However, soft margins and adverse currency may be deterrents.

Factors Likely to Shape Colgate's (CL) Q1 Earnings Outcome

CBRE Group

Mastercard

Moody's

MSCI

NIKE

Charles Schwab

Wells Fargo

Fund manager Brian Yacktman selects companies that can maintain sales growth and pricing power over many years.

Deep Dive: These ‘global champions’ may be your best bet for long-term stock investing

AbbVie

A. O. Smith

Cardinal Health

Federal Realty Investment Trust

General Dynamics

Hormel Foods

Coca-Cola

Walgreens

Dividend aristocrats and kings have proven themselves a great way to enjoy safe and growing dividends, even in recession, plus market-beating returns over time.

Bunker Dividend Growth Portfolio: Our Newest Dividend Aristocrat

Colgate struggles with strained margins for quite a while now. Nevertheless, the company's cost-savings program appears encouraging.

Can Colgate's Cost-Savings Programs Offset Margin Woes?

McDonald's

Procter & Gamble

Exxon Mobil

We decided to once again screen the Merrill equity research database for conservative stocks that are rated Buy, pay dividends and have the firm’s best (or lowest) volatility risk rating.

News for Colgate-Palmolive Stock (CL)